This post was just published on ZYX Buy Change Alert
MAKO Surgical Corp (MAKO) markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures. The stock has been depressed after reporting earnings that did not meet Wall Streets expectations. The big down swing in MAKO is a buying opportunity.
Use of robotics in surgery will continue to grow and this company is perfectly situated. Please note that like most young companies in the surgical robotics field this is a speculative stock with high risk of loss but also potential of high rewards.
Due to the speculative nature of the stock and overall market conditions, we recommend not exceeding the maximum position size of 30% of the full core position size. Most subscribers may consider starting only a 10% initial tranche right here.
Buy zone is $21. to $23.
Target zone $36. to $40.
Stop zone: temporarily none
